Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Identification and Characterization of a Glucometabolic Prognostic Gene Signature in Neuroblastoma based on N6-methyladenosine Eraser ALKBH5

1 Jan 2022

Abstract excerpt

Background: Neuroblastoma (NB) is a pediatric cancer occurring in the peripheral nervous system. A demethylase, alkylation repair homolog protein 5 (ALKBH5), is one type of N6-methyladenosine (m6A) eraser that plays a tumor-suppressive role in a variety of cancers. The significance of carbohydrate metabolism in cancer has been intensively investigated over the years, but the correlation between ALKBH5 and glucose...

Topics

Join the communities discussing this publication.

Cancer, Hypoxia, and Metabolism
Neuroblastoma Research and Treatments
RNA modifications and cancer

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 35517412
DOI: 10.7150/jca.69408

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification and Characterization of a Glucometabolic Prognostic Gene Signature in Neuroblastoma based on N6-methyladenosine Eraser ALKBH5PMID 35517412Read ↗

A prognostic metabolism-related gene signature associated with the tumor immune microenvironment in neuroblastomaSemantic proximity Read ↗

Amino Acid Metabolism Subtypes in Neuroblastoma Identifying Distinct Prognosis and Therapeutic Vulnerabilities.Semantic proximity Read ↗

Joint analysis of the metabolomics and transcriptomics uncovers the dysregulated network and develops the diagnostic model of high-risk neuroblastomaSemantic proximity Read ↗

Metabolism and Tumor Microenvironment-Associated Molecular Classification of NeuroblastomaSemantic proximity Read ↗

Combined analysis of RNA-sequence and microarray data reveals effective metabolism-based prognostic signature for neuroblastoma.Semantic proximity Read ↗

Identification of HBA2 and NR4A2 as potential prognostic molecular markers of MYCN amplified neuroblastomaSemantic proximity Read ↗

Joint metabolomics and transcriptomics analysis systematically reveal the impact of MYCN in neuroblastomaSemantic proximity Read ↗

RNA N6-methyladenosine reader IGF2BP3 interacts with MYCN and facilitates neuroblastoma cell proliferationSemantic proximity Read ↗

Identification of prognostic biomarkers in neuroblastoma using WGCNA and multi-omics analysisSemantic proximity Read ↗

Identification of N6-Methyladenosine-Related Gene Based Prognostic Signature to Predict Survival and Potential Therapeutic Drugs in GliomaSemantic proximity Read ↗

DNAJC12 downregulation induces neuroblastoma progression via increased histone H4K5 lactylationSemantic proximity Read ↗

ALDOC promotes neuroblastoma progression and modulates sensitivity to chemotherapy drugs by enhancing aerobic glycolysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.